ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.906,08
-0,49%
S&P 500
5.942,47
1,26%
Dow Jones
42.732,13
0,80%
Euro vs US Dollar
1,03115
0,00%
Bitcoin
97.774,13
-0,44%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSXV

  6. Sernova Corp (SVA) Börsenkurse

Sernova Corp

Sernova Corp (SVA)

Simavita Ltd
Sinovac Biotech Ltd
Sernova Corp
1,57
0,00
(0,00%)
Geschlossen 05 Januar 10:00PM
Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
1,57
Gebot
1,55
Fragen
1,61
Volumen
-
0,00 Tagesbereich 0,00
1,57 52-Wochen-Bereich 1,57
Marktkapitalisierung
510,76M
Handelsende
1,57
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
325.325.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,42
Gewinn pro Aktie (EPS)
-0,1
Erlöse
-
Nettogewinn
-32,19M

Über Sernova Corp

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.sernova.com
Hauptsitz
Vancouver, British Columbia, Can
Gegründet
-
Sernova Corp is listed in the Pharmaceutical Preparations sector of the TSX Venture Börse with ticker SVA. The last closing price for Sernova was $1,57. Over the last year, Sernova shares have traded in a share price range of $ 1,57 to $ 1,57.

Sernova currently has 325.325.000 shares in issue. The market capitalisation of Sernova is $510,76 million. Sernova has a price to earnings ratio (PE ratio) of -2.42.

SVA Neueste Nachrichten

Weitere Nachrichten

Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing

NEW YORK, March 29, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from the March 25th conference are now available for on-demand viewing at...

29 März 2021
GlobeNewswire Inc.

Sernova to Webcast Live at Life Sciences Investor Forum March 25th

LONDON, Ontario, March 22, 2021 (GLOBE NEWSWIRE) -- Sernova Corp. (OTCQB:SEOVF)(TSX-V:SVA)(FSE/XETRA:PSH), a leading clinical-stage company focused on developing regenerative medicine...

22 März 2021
GlobeNewswire Inc.

Virtual Conference for Life Sciences Companies Broadcast Live March 25th, 2021

NEW YORK , March 19, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry...

19 März 2021
GlobeNewswire Inc.

PURA SVA - Health Stocks Exhibit Healthy News, Robust Share Hikes

BAYSTREET -- June 18, 2020 -- InvestorsHub NewsWire -- via Glenn Wilkins --  It’s probably the farthest from the minds of many North Americans, given the worry over the...

18 Juni 2020
InvestorsHub NewsWire

Sernova Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in Phase I/II Clinical Trial for Type-A

Sernova Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in its Phase I/II Clinical Trial for Type-1 Diabetes   Findings further validate Cell Pouch and...

16 Oktober 2019
InvestorsHub NewsWire

Sernova Announces First Transplantation of Therapeutic Cells in Cell Pouch for the Company's Phase I/II U.S. Clinical Study

Sernova Announces First Transplantation of Therapeutic Cells in Cell Pouch for the Company's Phase I/II U.S. Clinical Study for Diabetes LONDON, ONTARIO, CANADA -- April 11, 2019 -- InvestorsHub...

11 April 2019
InvestorsHub NewsWire

Sernova Completes Oversubscribed Private Placement of $2,754,000

LONDON, Ontario, July 23, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH) announces it has completed a non-brokered private placement of $2.754 million, pursuant to...

23 Juli 2018
GlobeNewswire Inc.

Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for Diabetes

Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for DiabetesLondon, ON -- July 5, 2018 -- InvestorsHub NewsWire -- Sernova Corp. (“Sernova” or the...

05 Juli 2018
InvestorsHub NewsWire

Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for Diabetes

LONDON, Ontario, July 05, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (“Sernova” or the “Company”) (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH) announces that patient screening and recruitment has begun in...

05 Juli 2018
GlobeNewswire Inc.

Sernova Announces University of Chicago Institutional Review Board (IRB) Approval of the FDA-cleared Therapeutic Cell Pouch C...

LONDON, Ontario, May 14, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH), announces today it has received University of Chicago Institutional Review Board (IRB...

14 Mai 2018
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1001.571.571.5700CS
4001.571.571.5700CS
12001.571.571.5700CS
26001.571.571.5700CS
52001.571.571.5700CS
156-0.34-17.80104712041.912.221.3400391.59161179CS
2601.395797.1428571430.1752.870.0952184441.12509578CS

SVA - Frequently Asked Questions (FAQ)

What is the current Sernova share price?
The current share price of Sernova is $ 1,57
How many Sernova shares are in issue?
Sernova has 325.325.000 shares in issue
What is the market cap of Sernova?
The market capitalisation of Sernova is CAD 510,76M
What is the 1 year trading range for Sernova share price?
Sernova has traded in the range of $ 1,57 to $ 1,57 during the past year
What is the PE ratio of Sernova?
The price to earnings ratio of Sernova is -2,42
What is the reporting currency for Sernova?
Sernova reports financial results in CAD
What is the latest annual profit for Sernova?
The latest annual profit of Sernova is CAD -32,19M
What is the registered address of Sernova?
The registered address for Sernova is SUITE 1500 - 1055 WEST GEORGIA STREET, VANCOUVER, BRITISH COLUMBIA, V6E 2N7
What is the Sernova website address?
The website address for Sernova is www.sernova.com
Which industry sector does Sernova operate in?
Sernova operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MUST.HMust Capital Inc
$ 0,06
(200,00%)
165k
KUAI.PKua Investments Inc
$ 0,045
(125,00%)
14k
CRBKCarebook Technologies Inc
$ 0,095
(111,11%)
420,1k
CPLCopper Lake Resources Ltd
$ 0,01
(100,00%)
9k
VKG.HNorse Gold Corp
$ 0,02
(100,00%)
2,16k
TVITVI Pacific Inc
$ 0,005
(-50,00%)
11k
MTBMTB Metals Corp
$ 0,01
(-50,00%)
116,4k
ETUE2gold Inc
$ 0,005
(-50,00%)
10k
KOVOKovo+ Holdings Inc
$ 0,035
(-41,67%)
15k
PORPortofino Resources Inc
$ 0,01
(-33,33%)
349k
MATEBlockmate Ventures Inc
$ 0,41
(38,98%)
9,03M
DMDataMetrex AI Limited
$ 0,005
(0,00%)
4,48M
THRMTherma Bright Inc
$ 0,04
(14,29%)
3,45M
GPUSAlset AI Ventures Inc
$ 0,16
(-3,03%)
2,41M
SSESilver Spruce Resources Inc
$ 0,005
(0,00%)
2,14M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

TSXV
SVA
Sernova
BIT
WAGAIN
Warr Cloudia Research 2325
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten